AcuityMD In the news

Compliance Fears Are Stalling AI In Medtech Sales, Even As Sales Reps Who Use It Outperform

July 23, 2026

MedTech Insight

An AcuityMD-sponsored survey of 150 medtech reps finds AI users 3x likelier to hit quota — but only 36% use AI, and 11% for strategic work. Compliance, training gaps and generic tools stall adoption. The device-maker question, sources argue, is now how to deploy AI, not whether.

The new medtech sales pitch to providers runs on AI. Here’s how.

May 13, 2026

ModernHealthcare.com

Artificial intelligence has entered the world of sales calls, and it is changing the conversations between providers and MedTech companies seeking to close a deal.

AcuityMD raises $80M to help bolster AI in the MedTech industry

April 22, 2026

Fierce Biotech

AcuityMD has raised $80 million—with a company valuation now nearing $1 billion—to use its artificial intelligence (AI) platform to boost multiple aspects of how MedTech companies operate.

Exclusive: AcuityMD raises $80M for AI-aided MedTech sales

April 21, 2026

Axios Pro

MedTech software platform AcuityMD raised $80 million in Series C funding at a $955 million valuation, CEO Michael Monovoukas tells Axios Pro exclusively.

How MedTech Companies Can Deliver Innovative Care to More Veterans

April 2, 2026

Medical Product Outsourcing

Through the illustration of a real-world case, this article shares how a company was able to penetrate the VA healthcare system with a data management solution.

MarComm Tech in 2026

February 12, 2026

PharmaLive.com

AcuityMD CRO Alex Wakefield shares what MedTech companies have to do to optimize and maximize the effectiveness of their sales rep teams in the new year and going forward.

From OR to Office: How Workflow Change and AI Are Reshaping MedTech Adoption

February 3, 2026

PharmExec.com

Dave Carey, CEO, Preceptis Medical and Michael Monovoukas, CEO, co-founder, AcuityMD note the importance of shifting ear tube procedures into the office, reducing anesthesia risk, and how AI-driven data and adaptive commercial strategies are becoming critical to scaling new MedTech innovations.

Industry Leaders Predict Life Science Trends for 2026

January 27, 2026

The Scientist

2026 will be the year that artificial intelligence accelerates multiple aspects of the medical technology discovery and development pipeline, industry leaders predict.

Inside 2026: The Industry’s AI Turning Point

January 7, 2026

The Medicine Maker

The life sciences sector is bracing for a year when AI delivers real returns, regulators move faster, and trial operations are finally built for modern science.

MedTech Ends 2025 at Strategic Crossroads as AI Matures, IPO Windows Reopen and M&A Re-Accelerates

January 5, 2026

MedTech Insight

Alex Wakefield, AcuityMD Chief Revenue Officer, predicts that in 2026 MedTech commercial teams will favor weekly sprints like tech companies use over static annual plans.

AcuityMD Predicts AI Will Drive Operational Change Across MedTech in 2026

December 31, 2025

Discover Pharma

Mike Monovoukas, CEO and co-founder, and Alex Wakefield, Chief Revenue Officer at AcuityMD share their predictions on how AI will change how MedTech commercial teams operate and prove clinical and financial value in 2026.

MedTech Industry Predictions for 2026

December 18, 2025

MedTech Insights

Mike Monovoukas, CEO and co-founder of AcuityMD, and Alex Wakefield, Chief Revenue Officer of AcuityMD, share their predictions for the MedTech industry in 2026.

Predictions from MedTech Industry Leaders for 2026

December 15, 2025

ACRP

Alex Wakefield, Chief Revenue Officer at AcuityMD, joins other healthcare and MedTech leaders to offer their 2026 predictions for the industry.

The Key MedTech, Health Tech Trends Changing in 2026

November 19, 2025

MDDI Online

AcuityMD experts predict AI will redefine the MedTech value demonstration in 2026, with commercial teams being forced to adapt faster than ever.

Lumos Diagnostics Tightens US Commercial Focus with AcuityMD Collaboration

November 19, 2025

Proactive Investors

Lumos Diagnostics has signed a strategic collaboration with AcuityMD to sharpen visibility around real-world reimbursement patterns. The partnership is designed to help Lumos navigate one of the most critical — and most challenging — levers in US diagnostic adoption: establishing dependable, repeatable reimbursement across private and public payers.

Preceptis Medical Selects AcuityMD for Expansion of Breakthrough In-Office Pediatric Ear Tube Device

October 21, 2025

Medical Device News Magazine

In recognition of Children’s Health Month, AcuityMD, the AI platform for MedTech, announced that Preceptis Medical has selected its platform to support an expanded market launch of the Hummingbird® Tympanostomy Tube System (TTS).

AcuityMD Expands AI Platform to Boost MedTech Sales Performance

October 8, 2025

Medical Design & Outsourcing

AcuityMD, the AI platform for MedTech, announced today at its annual Flywheel event for commercial leaders a major expansion of its platform with new AI tools to give medical device companies visibility into forecasted sales performance, business risks, and next-best actions to reach their goals.

MedTech M&A Surges in 2025: Why Startups Are Now Ripe for Acquisition

September 4, 2025

HIT Consultant

After a few mixed years in medical technology mergers and acquisition activity, 2025 is shaping up to be a landmark year, particularly among cash-rich medical device strategics. In Q1 2025, there were 57 MedTech M&A transactions totaling $9.2 billion, compared to 62 deals worth $2.7 billion in Q1 2024, according to J.P. Morgan’s MedTech sector report.

Next Billion Dollar Startups 2025

August 12, 2025

Forbes

We’re honored to be recognized by Forbes among the world’s most promising companies shaping the future. This recognition is more than just a milestone; it’s a reflection of our team’s relentless commitment to accelerating the adoption of cutting-edge medical technologies.

MedTech M&A Resurges: How To Define Startup Exit Strategy

August 4, 2025

MedTech Insight

The MedTech M&A landscape is experiencing a resurgence fueled by significant capital from private equity and venture firms, says Alex Wakefield, CRO of AcuityMD. Building strong relationships with physicians remains crucial in MedTech, and defining an exit strategy early is imperative.

Mapping the Patient Journey: How MedTech Companies Are Solving Healthcare's Referral Challenges

July 29, 2025

MDDI Online

Medical device companies are changing healthcare delivery by using advanced commercial intelligence platforms that track complete patient journeys across providers, diagnoses, and treatments, solving the persistent challenge of murky referral networks.

America's Greatest Startup Workplaces 2025

March 25, 2025

Newsweek

Newsweek and data research firm Plant-A Insights Group are proud to present America's Greatest Startup Workplaces 2025. This list spotlights 250 exceptional companies across the U.S. that have created dynamic, supportive and rewarding environments for their employees.

AcuityMD Presents New Outpatient Spinal Surgery Data at American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting

March 15, 2025

Healthcare Business Today

Share of spinal surgeries performed in an outpatient setting increasing 8% year over year – improving patient experience, reducing financial burden, creating opportunities for device companies.

New AcuityMD Data Reveals Rapid Shift of Spinal Surgeries into ASCs

March 13, 2025

Ambulatory Surgery Center News

AcuityMD, a commercial intelligence platform for the MedTech industry, unveiled new data at the American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting related to the shift of higher-acuity procedures into outpatient settings. AcuityMD used U.S. Centers for Medicare & Medicaid Services (CMS) data and over 300 million patient claims to conduct its research.

AAOS 2025: AcuityMD Study Finds Innovation Continues To Drive Outpatient Spinal Procedures

March 13, 2025

MedTech Insight

A new study by AcuityMD, presented at AAOS 2025, highlights the continued shift of spinal surgeries to the outpatient setting, with state-by-state variability in ASC adoption. While hospitals still dominate spinal procedures, advancements in minimally invasive techniques and medical technologies are major drivers of spinal surgeries in the ASC setting.

How Profound Medical Leveraged MedTech Intelligence to Power Its Commercial Strategy

March 11, 2025

MDDI Online

The MedTech sector faces growing commercialization challenges, but leveraging precise market intelligence can help companies, particularly startups, optimize strategies, and improve product adoption.

States With the Highest, Lowest Growth Rate of Spine Surgery in the ASC Setting

March 6, 2025

Becker's Spine Review

Between 2021 and 2024, the share of spine surgeries performed in the ASC setting has grown by 8% year over year, according to data from MedTech intelligence platform AcuityMD.

The Potential and Pitfalls of AI in Health Care

February 17, 2025

MedAdNews

Companies that can see through the hype of AI and focus on the instances that will create actual value will avoid distractions and missteps that cost them time and money. The true opportunity in AI solutions is to give people and organizations a chance to enhance their existing abilities, accentuating and extending their best skillsets.

A New Frontier

February 17, 2025

MedAdNews

With a new administration in Washington, new AI and data tools, new approaches to omnichannel communications, and new ways to target and engage HCPs and patients at ever more granular levels, 2025 seems likely to look very much unlike what’s come before.

What Will Have a Major Impact on Healthcare Communications in 2025?

February 16, 2025

MedAdNews

We asked our contributors what we missed – what didn’t we ask about that will have a major impact on healthcare communications this year. This is what they told us.

Medical Device Contract Management: A Leaky Valve in Company Profits

October 5, 2024

MDDI Online

A recent survey reveals that 100% of MedTech executives believe poor contract management significantly impacts revenue. Effective contract management is crucial for boosting profit margins in the stagnating MedTech industry

AcuityMD Raises $45M for MedTech Sales Analytics

August 13, 2024

Axios Pro

AcuityMD announced $45 million in new funding to expand its commercial intelligence platform and advance the company's mission of accelerating adoption of cutting-edge MedTech.

Controlling the Chaos of MedTech Contracts

March 15, 2024

MDDI Online

AcuityMD co-founder and CEO Mike Monovoukas details how MedTech innovators are missing out on substantial revenue opportunities while incurring administrative costs from disjointed contract management.

Med Ad News Agenda 2024 Covers AI and Beyond

March 5, 2024

MedAdNews

Too often, MedTech companies send reps data dumps – clunky spreadsheets or standalone reports – expecting them to make sense of it all. Reps are salespeople, not data analysts. For them to be successful, they need easy-to-use and intuitive data that quickly identifies the best opportunities and helps them better understand prospective buyers," says Mike Monovoukas, CEO and co-founder at AcuityMD.

Artificial Intelligence, Consolidated Healthcare, and Obesity Drugs to Impact MedTech 2024

December 19, 2023

PharmaLive.com

CEO and co-founder Mike Monovoukas sits down with MedAd News and PharmaLive to discuss the top trends in store for 2024.

Analyzing Data in the Medical Device Marketing Landscape

November 28, 2023

TechTarget

Understanding how to analyze and leverage data for medical device marketing is critical to product launch success. In this Life Sciences Intelligence article, learn why it’s critical for MedTech companies to understand their ICP (Ideal Customer Profile) even beyond product launch, and predictions for what 2024 will bring to the MedTech space.

40 Under 40: Michael Monovoukas

October 10, 2023

Boston Business Journal

Boston Business Journal profiles co-founder and CEO Mike Monovoukas in their 40 Under 40 feature, recognizing Boston's best and brightest young professionals.

Anika Therapeutics Streamlines Path to Commercialization

August 9, 2023

PharmaLive.com

While MedTech commercialization is complex and different for each product, having a platform that efficiently and accurately identifies new opportunities is invaluable. In this article, Anika Therapeutics shares how new data insights enabled their sales reps to drive more effective call plans -- surfacing over 500 relevant surgeons and more than $20 million in pipeline opportunities.

Four Pillars for a Successful MedTech Market Product Launch

July 4, 2023

MDDI Online

Successfully introducing a product into the MedTech market can be challenging. Now, experts are carving out a clearer pathway.

Mike Monovoukas of AcuityMD Named ELITE 2023 Digital Crusader

May 16, 2023

PM360

Digital Crusaders are those who advance digital platforms to transform marketing and company operations. With AcuityMD, Mike identified a clear industry need and is helping MedTech companies bring innovations to market that positively impact patients’ lives.

Dilon Deploys AcuityMD’s Platform to Accelerate Treatment for Patients

April 5, 2023

Medical Device Network

AcuityMD’s platform enables Dilon to quickly identify physicians to treat surgical breast cancer patients.

Are Dated Software Systems Holding Back MedTech?

January 11, 2023

Med-Tech News

Are dated software systems holding MedTech back? AcuityMD CEO Michael Monovoukas shares what medical technology companies can achieve when they have the right tools -- and the risks if they don't.

Trends That Could Define MedTech’s Success in 2023

January 3, 2023

MDDI Online

The top trend that could define MedTech in 2023? Empower your salesforce (or lose your people), according to MD+DI. "The smart companies are going to be the ones that wake up to that earlier and start investing in empowering their salesforce as opposed to monitoring or taking a Big Brother approach," says AcuityMD CEO Michael Monovoukas.

AcuityMD Named Pharmaceutical Marketing Venture to Watch

December 13, 2022

PharmaLive.com

"A lot of folks have taken almost a pejorative framing, describing the medical technology industry as behind pharma or behind other industries,” Monovoukas told Med Ad News. "The reality is the medical device industry has never had a tool that was built with their own needs and use cases in mind."

Could Minimally Invasive Neuromod Tackle the Opioid Epidemic?

November 21, 2022

Medical Design & Outsourcing

Officials at Spark Biomedical and AcuityMD think their partnership could accelerate the commercialization of Spark’s potentially game-changing platform.

Spark Biomedical and AcuityMD Partner to Launch Non-Drug Opioid Reduction System

November 15, 2022

Becker's Spine Review

To accelerate patient access to its non-pharmaceutical therapy for opioid use disorder, Spark Biomedical has teamed up with AcuityMD on the launch of a wearable neurostimulation device.

AcuityMD Raises $31M to Make Data from Medical Devices Actionable

May 12, 2022

Vator News

Like much of healthcare, medical devices data is siloed. That means that manufacturers lose visibility on the patient after they sell the device, providers have trouble keeping up with the increasing pace of innovation, and payers reimburse healthcare providers without knowing which products were used. AcuityMD is a platform looking to close those gaps.

AcuityMD Raises $7M to Better Track the Evolving World of Medical Hardware

May 25, 2021

TechCrunch

“There are thousands of products being launched each year and so it’s almost impossible for a surgeon, after they’ve graduated fellowship or residency to keep track of the latest and greatest medical technology out there,” Monovoukas said. “We view this as a software and coordination problem, where you have all this data out there and it’s inefficient in getting to the decision-maker.”